Similar articles

• Safety of recombinant activated factor VII in randomized clinical trials.

  Yank V, Stafford RS. Yank V, et al. N Engl J Med. 2011 Feb 10;364(6):575; author reply 575-6. doi: 10.1056/NEJMc1013591. N Engl J Med. 2011. PMID: 21306248 No abstract available.
• Off-label use of recombinant activated factor VII--safe or not safe?

  Aledort LM. Aledort LM. N Engl J Med. 2010 Nov 4;363(19):1853-4. doi: 10.1056/NEJMe1008857. N Engl J Med. 2010. PMID: 21047230 No abstract available.
• Safety of recombinant activated factor VII in randomized clinical trials.

  Arellano-Rodrigo E. Arellano-Rodrigo E. N Engl J Med. 2011 Feb 10;364(6):574-5; author reply 575-6. doi: 10.1056/NEJMc1013591. N Engl J Med. 2011. PMID: 21306249 No abstract available.
• Review of the off-label use of recombinant activated factor VII in pediatric cardiac surgery patients.

  Guzzetta NA, Russell IA, Williams GD. Guzzetta NA, et al. Anesth Analg. 2012 Aug;115(2):364-78. doi: 10.1213/ANE.0b013e31825aff10. Epub 2012 May 31. Anesth Analg. 2012. PMID: 22652310 Review.
• Recombinant factor VIIa: an assessment of evidence regarding its efficacy and safety in the off-label setting.

  Logan AC, Goodnough LT. Logan AC, et al. Hematology Am Soc Hematol Educ Program. 2010;2010:153-9. doi: 10.1182/asheducation-2010.1.153. Hematology Am Soc Hematol Educ Program. 2010. PMID: 21239786 Review.